Peptonic Medical (publ) ("Peptonic" or "the Company") is expanding its product portfolio in the field of intimate care and launching VagiVital Moisturizing Intimate Cream, a moisturizing intimate cream specifically developed for external application to the vulva. The product is aimed at women who experience dryness and discomfort in the external areas of the intimate region and represents a strategically important addition to VagiVital's growing premium range in modern intimate care.
The launch is part of Peptonic's long-term strategy to establish VagiVital as a leading, comprehensive brand in intimate self-care, with innovative products that meet women's varying needs throughout the different stages of life.
VagiVital Moisturizing Intimate Cream complements the Company's existing product portfolio and strengthens its offering in moisturization, comfort, and intimate balance. Many women today use VagiVital AktivGel for vaginal moisturization and the treatment of dry mucous membranes, while VagiVital Intimate Calming Gel offers soothing care for irritation and sensitivity in the vulva. With the new Moisturizing Intimate Cream, Peptonic is now further expanding its offering with a more intensely nourishing and softening cream for the external areas of the intimate region-enabling the company to provide a more complete solution for intimate care.
"With VagiVital Moisturizing Intimate Cream, we are strengthening our offer in intimate moisturization and taking another step toward building a complete and leading brand in women's intimate health. The product naturally complements our existing range and allows us to meet more of the needs of women seeking gentle, effective, and high-quality intimate care," says Daniel Rudeklint, Interim CEO of Peptonic Medical AB.
VagiVital Moisturizing Intimate Cream is designed for use as needed and is enriched with carefully selected ingredients focused on moisturization, care, and comfort. The cream is enriched with shea butter and sunflower oil, which soften and nourish dry and sensitive skin, while lactic acid helps support the intimate area's natural pH balance. The product also contains xylitol, which contributes to intense and long-lasting hydration. Together, the ingredients provide a soothing, long-lasting, and moisturizing effect while supporting the skin's natural barrier.
The product is part of VagiVital's growing family of intimate care products, alongside VagiVital AktivGel and VagiVital Intimate Calming Gel, among others. The launch aligns with Peptonic's ambition to make intimate care more accessible, modern, and demystified-with products that combine science, quality, and women's real-life needs.
VagiVital Moisturizing Intimate Cream is scheduled for launch in the second half of 2026.
For further information, please contact:
Daniel Rudeklint, Interim CEO, Peptonic Medical AB
Email: daniel.rudeklint@peptonicmedical.se
Phone: +46 73 158 02 73
About Peptonic Medical AB
Peptonic Medical AB (publ) is a Swedish medical technology company that develops and sells clinically proven self-care products for women's intimate health. Under the VagiVital and Vernivia brands, the Company offers an over-the-counter portfolio of effective and gentle products that help women understand, treat, and prevent common gynecological conditions. Peptonic's growth strategy is based on geographic expansion, particularly in the U.S. and Europe, and on continuously strengthening the product portfolio through in-house product development and strategic acquisitions.
The Company is headquartered in Stockholm, Sweden, and has subsidiaries Peptonic Medical Inc. and Common Sense Marketing Inc. in the U.S. Peptonic Medical was founded in 2009 and has been listed on the Spotlight Stock Market since 2014.